It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cryptosporidium parvum is known to cause life-threatening diarrhea in immunocompromised hosts and was also reported to be capable of inducing digestive adenocarcinoma in a rodent model. Interestingly, three carcinogenic isolates of C. parvum, called DID, TUM1 and CHR, obtained from fecal samples of naturally infected animals or humans, showed higher virulence than the commercially available C. parvum IOWA isolate in our animal model in terms of clinical manifestations, mortality rate and time of onset of neoplastic lesions. In order to discover the potential genetic basis of the differential virulence observed between C. parvum isolates and to contribute to the understanding of Cryptosporidium virulence, entire genomes of the isolates DID, TUM1 and CHR were sequenced then compared to the C. parvum IOWA reference genome. 125 common SNVs corresponding to 90 CDSs were found in the C. parvum genome that could explain this differential virulence. In particular variants in several membrane and secreted proteins were identified. Besides the genes already known to be involved in parasite virulence, this study identified potential new virulence factors whose functional characterization can be achieved through CRISPR/Cas9 technology applied to this parasite.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Gènes Diffusion, 3595, route de Tournai, Douai, France; PEGASE-Biosciences, Institut Pasteur de Lille, Lille, France (GRID:grid.8970.6) (ISNI:0000 0001 2159 9858)
2 Bilille, Institut Pasteur de Lille, Lille, France (GRID:grid.8970.6) (ISNI:0000 0001 2159 9858)
3 PEGASE-Biosciences, Institut Pasteur de Lille, Lille, France (GRID:grid.8970.6) (ISNI:0000 0001 2159 9858); Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 – UMR 8204 – CIIL – Centre d’Infection et d’Immunité de Lille, Lille, France (GRID:grid.410463.4) (ISNI:0000 0004 0471 8845)
4 Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 – UMR 8204 – CIIL – Centre d’Infection et d’Immunité de Lille, Lille, France (GRID:grid.410463.4) (ISNI:0000 0004 0471 8845)
5 Bilille, Institut Pasteur de Lille, Lille, France (GRID:grid.8970.6) (ISNI:0000 0001 2159 9858); CNRS, Univ. Lille, Inria, UMR 9189 - CRIStAL - Centre de Recherche en Informatique Signal et Automatique de Lille, Lille, France (GRID:grid.503422.2) (ISNI:0000 0001 2242 6780)
6 Gènes Diffusion, 3595, route de Tournai, Douai, France (GRID:grid.503422.2); PEGASE-Biosciences, Institut Pasteur de Lille, Lille, France (GRID:grid.8970.6) (ISNI:0000 0001 2159 9858)
7 Service d’Anatomie et de Cytologie Pathologiques, Groupement des Hôpitaux de l’Institut Catholique de Lille (GHICL), Lille, France (GRID:grid.488857.e) (ISNI:0000 0000 9207 9326)
8 Plateforme d’Expérimentations et de Hautes Technologies Animales, Institut Pasteur de Lille, Lille, France (GRID:grid.8970.6) (ISNI:0000 0001 2159 9858)
9 Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 – UMR 8204 – CIIL – Centre d’Infection et d’Immunité de Lille, Lille, France (GRID:grid.410463.4) (ISNI:0000 0004 0471 8845); Délégation à la Recherche Clinique et à l’Innovation, Groupement des Hôpitaux de l’Institut Catholique de Lille, Lille, France (GRID:grid.488857.e) (ISNI:0000 0000 9207 9326)
10 Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 – UMR 8204 – CIIL – Centre d’Infection et d’Immunité de Lille, Lille, France (GRID:grid.410463.4) (ISNI:0000 0004 0471 8845); Equipe Ecologie et biodiversité, Unité de Recherche Smart and Sustainable Cities, Faculté de Gestion Economie et Sciences, Institut Catholique de Lille, Lille, France (GRID:grid.417666.4) (ISNI:0000 0001 2165 6146)